Alberto
Carmona Bayonas
Asociado Ciencias de la Salud
Hospital Infanta Sofia
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Infanta Sofia (5)
2017
-
Clinical features and short-term outcomes of cancer patients with suspected and unsuspected pulmonary embolism: The EPIPHANY study
European Respiratory Journal, Vol. 49, Núm. 1
-
Dynamic soluble changes in sVEGFR1, HGF, and VEGF promote chemotherapy and bevacizumab resistance: A prospective translational study in the BECOX (GEMCAD 09-01) trial
Tumor Biology, Vol. 39, Núm. 6
2016
-
Outpatient management of cancer-associated pulmonary embolism (PE): analysis of lung carcinoma (LC) cohort from the Epiphany study
Annals of Oncology, Vol. 27, pp. vi513
2015
2014
-
First-line bevacizumab and capecitabine-oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study
British Journal of Cancer, Vol. 111, Núm. 2, pp. 241-248